Traders Buy Shares of UnitedHealth Group (UNH) on Weakness Following Insider Selling
Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Friday after an insider sold shares in the company. $918.12 million flowed into the stock on the tick-up and $190.06 million flowed out of the stock on the tick-down, for a money net flow of $728.06 million into the stock. Of all stocks tracked, UnitedHealth Group had the 2nd highest net in-flow for the day. UnitedHealth Group traded down ($1.87) for the day and closed at $251.40Specifically, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the sale, the director now owns 64,726 shares in the company, valued at approximately $16,400,921.14. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the sale, the director now owns 77,702 shares in the company, valued at approximately $20,716,130.22. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,930 shares of company stock worth $7,208,783. 0.87% of the stock is owned by company insiders.
A number of equities research analysts have issued reports on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 21st. Cantor Fitzgerald reaffirmed a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a report on Wednesday, November 21st. BMO Capital Markets set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, November 27th. Piper Jaffray Companies increased their price objective on shares of UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a report on Wednesday, November 28th. Finally, Oppenheimer increased their price objective on shares of UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, November 28th. Two equities research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $297.80.
The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $243.06 billion, a price-to-earnings ratio of 19.52, a price-to-earnings-growth ratio of 1.26 and a beta of 0.79.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Investors of record on Monday, March 11th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 27.95%.
Several hedge funds have recently bought and sold shares of the stock. Van Leeuwen & Company LLC boosted its stake in UnitedHealth Group by 4.1% during the fourth quarter. Van Leeuwen & Company LLC now owns 2,535 shares of the healthcare conglomerate’s stock worth $632,000 after buying an additional 101 shares during the period. American Century Companies Inc. boosted its stake in UnitedHealth Group by 12.8% during the fourth quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock worth $1,414,679,000 after buying an additional 644,872 shares during the period. Fulcrum Equity Management purchased a new position in UnitedHealth Group during the fourth quarter worth $637,000. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter worth $2,343,175,000. Finally, Actinver Wealth Management Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth $1,806,000. 85.80% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/traders-buy-shares-of-unitedhealth-group-unh-on-weakness-following-insider-selling/2896019.html.
About UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Insider Trading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.